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Avian H7N9 influenza viruses may pose a further threat to humans
by reassortment with human viruses, which could lead to generation
of novel reassortants with enhanced polymerase activity. We
previously established a novel statistical approach to study the
polymerase activity of reassorted vRNPs (Influenza Other Respir
Viruses. 2013;7:969-78). Here, we report the use of this method to
study recombinant vRNPs with subunits derived from human
H1N1, H3N2, and H7N9 viruses. Our results demonstrate that some
reassortant vRNPs with subunits derived from the H7N9 and other
human viruses can have much higher polymerase activities than the
wild-type levels.
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Background
Coinfections and reassortments of influenza viruses play
critical roles in the genesis of influenza pandemics. All
pandemic strains from the last three pandemics have
chimeric viral ribonucleoprotein (vRNP) complexes with
subunits derived from different hosts.1,2 Extensive studies
from the last two decades also indicated that vRNP complex
can control viral virulence and interspecies transmission.3–5
Molecular markers associated with host adaptations in vRNP
complex were also identified.6,7
The recent detection of avian H7N9 influenza virus in
humans is of great concern. The virus was controlled in
May 2013 after poultry market closures and other inter-
ventions. However, the detection of new human cases since
October 2013 suggests that this virus is still circulating in
poultry and that zoonotic transmission to humans may
increase in winter season, when avian influenza activity in
poultry is known to increase.8 Alarmingly, coinfections of
avian H7N9 and human H3N2 viruses have been detected.9
It is possible that the H7N9 virus may generate a
reassortant of pandemic potential by reassortment with
seasonal human influenza viruses.
The study
We have recently reported the use of fractional factorial
design and statistical methods to analyze the polymerase
activity of recombinant vRNPs derived from three different
strains. By only characterizing a subset of recombinant
vRNPs (27 of all 81 possible combinations), we can use
multiway ANOVA to identify factors, including single vRNP
subunits and interactions between two vRNP subunits, that
control viral polymerase activity.10 Essentially, this statistical
approach can identify subunit combinations that can yield
robust polymerase activity without testing all possible vRNP
combinations. Here, we aim at applying this strategy to a
panel of reassorted vRNPs with subunits derived from the
human H7N9 (A/Shanghai/2/2013) virus and human influ-
enza viruses (H1N1: A/California/4/2009 and H3N2: A/HK/
405595/2009). In brief, 27 different chimeric vRNP combi-
nations were chosen by the 27-run fractional factorial design
(Figure 1) and were reconstituted in human 293T cells as
described.10 The H1N1, H3N2, and H7N9 wild-type vRNPs
were also reconstituted as controls. The transfected cells were
incubated at 33°C and 37°C for 48 hours before determining
their polymerase activity. All experiments were conducted in
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triplicate. Among the three wild-type vRNPs, the H3N2
vRNP had the highest polymerase activity at 33°C. For the
easy identification of recombinant vRNPs with enhanced
polymerase activity, all the polymerase activities were
expressed in relative to the H3N2 vRNP activity at the
corresponding temperature (Figure 1; see Supplementary
Figure for data without normalization). To identify vRNP
subunits or two-factor interactions that are important for
modulating polymerase activity, the deduced data were
analyzed by multiway ANOVA as described.10
Our statistical analysis indicated that the origin of the PB2
or PA gene segment is important for modulating polymerase
activity. Both H7N9 and H3N2 PB2 could stimulate poly-
merase activity as compared to H1N1 PB2 at 33°C and 37°C
(t-test, P < 001). Furthermore, H7N9 PA was found to have
a moderate stimulatory effect as compared to H3N2 PA at
37°C (t-test, P < 005), while H1N1 PA was found to have
the strongest stimulatory effect on polymerase activity at
both temperatures (t-test, P < 0001). The introduction of
H7N9 PB1 or NP did not have a significant effect on
polymerase activity at either temperature. We also validated
the above findings by conducting an independent experiment
using another fractional factorial design (i.e., another subset
of 27 chimeric vRNPs with different gene segment combi-
nations). The conclusions drawn from this independent
vRNP panel are identical to those as reported above (data not
shown). Overall, these results suggest that the vRNP gene
segments of H7N9 virus are generally well adapted in human
cells and can readily reassort with vRNP gene segments from
human H1N1 and H3N2 viruses.
To further confirm our observations, we generated a series
of chimeric vRNPs that are predicted to have robust
polymerase activities (Figure 2). When the PB2 of H1N1
vRNP was replaced by H3N2 or H7N9 PB2, the polymerase
activity increased significantly at both 33°C and 37°C as
predicted (Figure 2A, PB2 single factor). Replacing the PA of
H3N2 vRNP by H1N1 or H7N9 PA revealed that both H1N1
and H7N9 PA could enhance polymerase activity of the
H3N2 vRNP at both temperatures (Figure 2B, PA single
factor). In agreement with our statistical analysis, the
stimulatory effect caused by H1N1 PA in the H3N2 vRNP
was found to be more pronounced than that induced by the
PA of H7N9 (Figure 2B, PA single factor). This was further
confirmed by the introduction of H1N1 PA into the H7N9
vRNP, which showed that H1N1 PA can enhance polymerase
activity (Figure 2C, PA single factor).
Two-factor interactions which lead to enhanced polymer-
ase activity were also identified in our statistical analysis.
Our analysis revealed that the PB2–PA combination had the
most significant effect on determining the polymerase
activity. The analysis indicated that recombinant vRNPs
with H7N9/H3N2 PB2 and H1N1 PA have robust poly-
merase activities (t-test, P < 005). In addition, the PB1–PA
combination at 37°C was also found to be statistically
significant (t-test, P < 005), and vRNPs containing H7N9
PB1 and H1N1 PA were predicted to have robust polymer-
ase activity. To confirm these findings, we studied chimeric
vRNPs with these gene combinations (Figure 2). It was
observed that the introduction of H3N2/H7N9 PB2 and
H1N1 PA into the wild-type vRNPs could significantly
enhance polymerase activity (Figure 2A–C, PB2–PA inter-
action). Furthermore, when H7N9 PB1 and H1N1 PA were
introduced into wild-type vRNPs, the polymerase activity of
the reassorted vRNPs was also enhanced (Figure 2A–C,
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Figure 1. Mean relative polymerase activity of
chimeric vRNPs of different viruses from the
27-run fractional factorial design at different
temperatures. Twenty-seven chimeric vRNP
combinations originated from human H1N1
(H1), human H3N2 (H3), and human isolate of
avian H7N9 (H7) viruses were selected from the
27-run fractional factorial design. The chimeric
vRNPs were reconstituted in 293T cells at 33°C
(black) and 37°C (white). Mock transfection
(M) and wild-type H1N1, H3N2, and H7N9
vRNPs were used as control. The polymerase
activities of the chimeric vRNPs were studied by
luciferase reporter assay. The normalized data
are expressed as mean relative polymerase
activity in relative to the polymerase activity of
wild-type H3N2 vRNP at the corresponding
temperatures (n = 3). Error bars represent one
standard deviation.
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PB1–PA interaction). Overall, these data agree with our
predictions.
To test whether the above-identified factor or combina-
tions would have similar stimulatory effects on chimeric
vRNPs with subunits derived from H7N9 and recently
circulating human viruses, the vRNP gene segments of A/
HK/4259592/2013 (H1N1) and A/HK/4003076/2013 (H3N2)
were cloned and further studied. Recombinant vRNPs with
gene segment combinations identical to those as described in
Figure 2 were generated and characterized. Data from this
new set of chimeric vRNPs generally agreed with the
predictions. All the factors or combinations predicted to
have stimulatory effects in our initial analyses were found to
stimulate polymerase activity (Figure 3). It is worth noting
that there are some very minor differences between these two
set of chimeric vRNPs in terms of the degree of enhance-
ment. The vRNPs of A/HK/4259592/2013 and A/California/
4/2009 have a total of 18 amino acid differences, whereas the
vRNPs of A/HK/4003076/2013 and A/HK/405595/2009 have
16 differences (Supplementary Table). Further mutagenic
study on these positions might help to explain the effect of
these subtle variations on the polymerase activities. None-
theless, these results demonstrated that our predictions are
still applicable to contemporary seasonal viruses.
The H7N9 virus emerged and reemerged in humans in the
last several months. The chance of coinfection of seasonal
and H7N9 viruses in humans (or other mammalian species)
and the potential for emergence of novel reassortants of
H7N9 virus should not be overlooked. In fact, coinfections
and reassortments of influenza viruses have been detected in
humans in the past.11–13 The detection of a coinfection of
avian H7N9 and seasonal H3N2 viruses in human is of huge
public health concern.9 It should also be noted that the
hemagglutinin of H7N9 readily binds to alpha-2,6 sialic acid
receptor, which typically indicates the potential for human–
human transmission.14 It is possible that H7N9 might
acquire polymerase gene segment(s) from human influenza
viruses, resulting in a novel reassortant which is highly
adapted in humans.
Viral polymerase complexes with H3N2/H7N9 PB2 and
H1N1 PA were shown to have enhanced polymerase activity
at both 33°C and 37°C, suggesting that viruses with these
gene segment combinations might well adapted in both
human upper and lower respiratory tracts. Sequence analysis
of genes used in this study reveals that the H3N2 and H7N9
PB2 gene segments both have 627K, which is responsible for
high polymerase activity in human cells, while the H1N1 PB2
possesses the avian marker 627E. The PB2-627 polymor-
phism may partly explain the effect of PB2 on polymerase
activity observed in this study. On the other hand, the PA of
pandemic H1N1/2009 possesses three signature mutations
(T85I, G186S, and L336M) that might enhance polymerase
activity.15 However, it is not sure whether these PB2 and PA
A
B
C
Figure 2. Mean relative polymerase activity of wild-type and chimeric
vRNPs at different temperatures. Wild-type (A) H1N1 (H1), (B) H3N2 (H3),
or (C) H7N9 (H7) and chimeric vRNPs with different subunits were
reconstituted in 293T cells at 33°C (black) and 37°C (white). Mock-
treated cells (M) were used as controls. The polymerase activities of the
chimeric vRNPs were determined by luciferase reporter assay. The
normalized data are expressed as mean relative polymerase activity in
relative to the polymerase activity of wild-type (A) H1N1, (B) H3N2 or (C)
H7N9 vRNP at the corresponding temperatures, respectively (n = 3). Error
bars represent one standard deviation. (*P < 001, **P < 005, by t-test).
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mutations have a synergistic effect in enhancing polymerase
activity. The primary objective of this work was to study
the compatibility of vRNP subunits derived from the
representative strains selected, and further systematic muta-
genic studies will be needed to reveal how the interactions
between different subunits can affect polymerase activity.
To monitor the emergence of any new reassortant that
may lead to a new wave of epidemic or even a pandemic in
humans, all vRNP gene segments from human and animal
H7N9 cases should be at least partially sequenced. In
particular, our results showed that the introduction of PA
of pandemic H1N1 lineage can dramatically stimulate the
polymerase activity. Attention should therefore be paid to
future H7N9 reassortants which carry a PA derived from the
pandemic H1N1/2009 lineage.
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2013; H10), (B) H3N2 (A/HK/4003076/2013; H30), or (C) H7N9 (H7) and
chimeric vRNPs with different subunits were reconstituted in 293T cells at
33°C (black) and 37°C (white). Mock-treated cells (M) were used as
controls. The polymerase activities of the chimeric vRNPs were determined
by luciferase reporter assay. The normalized data are expressed as mean
relative polymerase activity in relative to the polymerase activity of wild-
type (A) H1N1, (B) H3N2, or (C) H7N9 vRNP at the corresponding
temperatures, respectively (n = 3). Error bars represent one standard
deviation (*P < 001 by t-test).
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